Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Montgomery, Stuart A., Baldwin, David S., Blier, Pierre, Fineberg, Naomi A., Kasper, Siegfried, Lader, Malcolm, Lam, Raymond W., Lépine, Jean-Pierre, Möller, Hans-Jürgen, Nutt, David J., Rouillon, Frederic, Schatzberg, Alan F., Thase, Michael E. · 2007 · International Clinical Psychopharmacology

Abstract

A review of published evidence of superior efficacy of a particular antidepressant in major depressive disorder may assist clinicians in making considered treatment choices. To identify such candidates, an international group of experts met to assess published evidence (identified through searches in Medline and Embase databases and discussions with experts in the field) from randomized, controlled trials and meta-analyses comparing two antidepressants under conditions of fair comparison. Criteria were defined to judge the strength of evidence. Two pivotal studies in moderate-to-severe major depressive disorder that demonstrate superiority on the primary efficacy measure, or alternatively one pivotal study supported by consistent results from meta-analyses, was considered to constitute evidence for definite superiority. Three antidepressants met these criteria: clomipramine, venlafaxine, and escitalopram. Three antidepressants were found to have probable superiority: milnacipran, duloxetine, and mirtazapine. Only escitalopram was found to have definite superiority in the treatment of severe depression; probable superiority was identified for venlafaxine and possible superiority for milnacipran and clomipramine. This review of published data found evidence that only a very few antidepressants are shown to be more effective than others.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/yic.0b013e3282eff7e0

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 165

Metadata

Authors
Montgomery, S. A., Baldwin, D. S., Blier, P., Fineberg, N. A., Kasper, S., Lader, M., Lam, R. W., Lépine, J.-P., Möller, H.-J., Nutt, D. J., Rouillon, F., Schatzberg, A. F., & Thase, M. E.
Venue
International Clinical Psychopharmacology
Published
2007-11
Volume
22
Issue
6
Pages
323-329
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2007245256
Cited by
165
References
2
FWCI
12.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Which antidepressants have demonstrated superior efficacy? A review of the evidence. https://app.cochat.ai/papers/10.1097/yic.0b013e3282eff7e0
The paper
Montgomery, S. A., Baldwin, D. S., Blier, P., Fineberg, N. A., Kasper, S., Lader, M., Lam, R. W., Lépine, J.-P., Möller, H.-J., Nutt, D. J., Rouillon, F., Schatzberg, A. F., & Thase, M. E. (2007). Which antidepressants have demonstrated superior efficacy? A review of the evidence. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e3282eff7e0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.